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Myostatin (MSTN) is a negative modulator of muscle mass. We characterized the horse (Equus caballus) MSTN gene and
identiﬁedandanalysedsinglenucleotidepolymorphisms(SNPs)inbreedsofdiﬀerentmorphologicaltypes.Sequencingofcoding,
untranslated,intronic,andregulatoryregionsofMSTN genein12horsesfrom10breedsrevealedsevenSNPs:twointhepromoter,
four in intron 1, and one in intron 2. The SNPs of the promoter (GQ183900:g.26T>C and GQ183900:g.156T>C, the latter located
within a conserved TATA-box like motif) were screened in 396 horses from 16 breeds. The g.26C and the g.156C alleles presented
higher frequency in heavy (brachymorphic type) than in light breeds (dolichomorphic type such as Italian Trotter breed). The
signiﬁcantdiﬀerenceofallelefrequenciesfortheSNPsatthepromoterandanalysisofmolecularvariance(AMOVA)onhaplotypes
indicates that these polymorphisms could be associated with variability of morphology traits in horse breeds.
1.Introduction
Myostatin, encoded by the MSTN gene (previously referred
to as GDF8), is a member of the transforming growth
factor β superfamily that normally acts to limit skeletal
muscle mass by regulating both the number and growth
of muscle ﬁbres [1, 2]. MSTN is synthesized as precursor
anduponproteolyticprocessinggivesanN-terminallatency-
associated peptide, termed myostatin propeptide or LAP-
fragment, and a smaller mature peptide at the C-terminus
[3]. The MSTN gene, composed of three exons and two
introns, has been characterized in rodents [1], humans [4],
and several livestock species [3, 5–8]. Natural mutations
that decrease the amounts of myostatin and/or inhibit its
function have been identiﬁed in a human subject [9]a n d
in several cattle [2, 3, 10–13], sheep [14–16], and dog [17]
breeds. In Belgian Blue, Piedmontese, Marchigiana, and
other cattle breeds, loss-of-function mutations within the
coding sequence of the MSTN gene determine increased
skeletal muscle mass, relevant in shoulders and thighs, and
the produced phenotype is known as “double-muscling”
[2, 3, 10–13, 18]. These polymorphisms have, in several
cases, eﬀects on growth, reproductive, performances, and
carcass quality traits [3, 18, 19]. In the Whippet dog breed
a mutation in the third exon determining a premature
stop codon causes an increased muscle mass phenotype
in homozygous state and enhanced racing performance in
heterozygous dogs [17]. In two Norwegian sheep breeds,
two diﬀerent mutations in the MSTN coding region are
associated with carcass conformation and fatness [15, 16]. In
addition, in other sheep and in pigs, mutations identiﬁed in
non coding regulatory regions aﬀect the level of MSTN gene
expression and/or are associated with growth, muscle mass,
and other carcass traits [8, 14, 20, 21].2 Journal of Biomedicine and Biotechnology
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Figure 1: Horses of extreme and opposite morphological types:(a) Rapid Heavy Draft (brachymorphic type or heavy) and (b) Italian Trotter
(dolichomorphic type or light).
In horse (Equus caballus), only few studies examined
the MSTN gene so far. Hosoyama et al. [22] isolated and
sequenced an MSTN cDNA from a Thoroughbred horse and
Caetano et al. [23] mapped this gene to equine chromosome
18. Mutations in the equine MSTN gene have been identiﬁed
only recently in Thoroughbred breed [24].
Diﬀerent horse breeds present a variety of morphological
phenotypes that have been used to group breeds into a few
classes. However, no system provides a robust classiﬁcation
in which each breed could have an unequivocal assignment.
Based on size traits and build, horse breeds are categorized
in draught (or heavy), light, and pony (or animals that
matureatlessthan148cmhigh,usuallyusedasridingschool
and children’s mounts) [25]. Considering skeletal structure,
proportions, zoometrical indices, length, and volume of
muscling, that, in turn, reﬂect the selective goals and uses
of the horse breeds, they are categorized in brachymor-
phic,mesomorphic,dolichomorphic,andintermediatetypes
(such as meso-dolichomorphic) [26]. Brachymorphic horses
(corresponding to draught horses), traditionally referred
to as cold-blooded horses in relation to their quiet and
calm temperament, are tall in stature, heavy boned, and
extremely muscular with short and thick muscles and slow
twitch oxidative ﬁbers for slow contraction. They most
likely develop strength and power, and their conformation
is well suited for pulling carriage, draught power and meat
production. Dolichomorphic horses (corresponding to light
horses) are characterized by longer bodies and long and thin
muscles mainly constituted by fast twitch glycolytic ﬁbers.
They are selected for sport purposes, fast running, and high
speeds.ExamplesofItalianbreedsrepresentativeofthesetwo
extreme phenotypes are reported in Figure 1. Mesomorphic
type is characterized by a lighter physical structure than
brachymorphic but still powerful and compact with massive
muscling. This group also includes some breeds with draft-
type qualities and classiﬁed as ponies based on their withers
height (such as Bardigiano and Haﬂinger breeds). The
mesomorphichorsesareusuallyusedforpleasureandriding.
In addition, several breeds (like local breeds with inﬂuence
of Oriental, Thoroughbred, and Iberian halfbreed and
descendents) have characteristics of both mesomorphic and
dolichomorphic types (referred to as meso-dolichomorphic)
[26].
For the important pleiotropic eﬀects of the MSNT
gene, including its role on muscle mass development,
polymorphisms in this gene could contribute to explain
the morphological variability among horse breeds. Here we
sequenced the MSTN gene, including regulatory regions, in
several horse breeds and identiﬁed a few polymorphisms
that were used to evaluate their potential association with
diﬀerent morphological types.
2.MaterialsandMethods
2.1. Animals and Horse Breeds Classiﬁcation Based on Dif-
ferent Morphological Types. A total of 396 minimal related
horses belonging to 16 breeds were sampled in diﬀerent
farms or stables. Details of the horse breeds involved in the
analysis are given in Table 1.
These horse breeds were classiﬁed as brachymorphic
(B), mesomorphic, (M), meso-dolichomorphic (M-D), and
dolichomorphic (D) (Table 1) as indicated in the homepage
of their own Breed National Associations based on linear
measures (height at withers, chest girth, and cannon cir-
cumference), structure and anamorphosis index (AI= (chest
girth)2∗100/height at wither), and based on bibliographic
data [27–30].
All horses were registered in the Stud Books or in
the Italian Anagraphic Register constituted for local ethnic
groups (Noric, Salernitano, Tolfetano, and Ventasso). The
Lipizzan samples (Lipizzan Italian Stud, Monterotondo,
Italy) included all six classical stallion lines: Conversano,
Favory, Maestoso, Neapolitano, Pluto, and Siglavy.
2.2.PCRandSequencing. Genomic DNA wasextractedfrom
hair roots following standard procedures. Ten primer pairs
(Table 2) that amplify diﬀerent MSTN regions were designed
using Primer 3 (http://frodo.wi.mit.edu/primer3/input.htm)
software. PCR reactions were performed in a ﬁnal volume of
20μL containing 10–80ng of equine genomic DNA, 250mM
of each dNTP, 10pmol of each primer, 1U of EuroTaq DNAJournal of Biomedicine and Biotechnology 3
Table 1: Numbers, types, origin, uses, and morphological information of the analysed horse breeds
∗.
International breed name (Home page of Breed National Associations) Types
§ Number of
horses
Origin of the
samples
Uses (adult animals,
males/females: withers
height, cm; live weight, kg)
Rapid Heavy Draft (http://www.anacaitpr.it/)B 8 1 North East of
Italy
Meat, draught power
(160/155cm; 700/570kg)
N o r i co rP i n z g a u e r(http://www.aia.it/tecnico/equini/a norico.htm)B 2 6 Alps, Northern
Italy
Draught power, driving,
carriage, dressage, meat
(155/153cm; 700/650kg)
Bardigiano (http://www.bardigiano.it/)M 3 4
Emilia
Romagna
region,
Northern Italy
Meat, agricultural work,
hobby (143/142cm;
530/480kg)
Haﬂinger or Avelignese (http://www.haﬂinger.it/) M 31 Northern Italy
Hobby, meat, draught
power (142/140cm;
450/450kg)
Lipizzan or Lipizzaner
(http://www.aia.it/tecnico/equini/a lipizzano.htm) M1 2 Rome, Central
Italy
Dressage, riding, carriage
(164/150cm; 550/480kg)
Murgese
(http://www.aia.it/tecnico/equini/download/DM%20MURGESE.pdf) M1 2 Apulia region,
Southern Italy
Riding, equestrian tourism,
draught power
(164/162cm; 550/480kg)
Tolfetano (http://www.aia.it/tecnico/equini/a tolfetan.htm)M 7 Latium region,
Central Italy Riding (160/150cm)
Uruguayan Creole or Criollo
(http://www.caballoscriollos.com.uy/homepage en.php) M3 5 U r u g u a y
Draught power,
government of livestock,
endurance (144/144cm;
420/420kg)
Italian Saddle (http://www.aia.it/ANACSI/Frame.htm)M - D 3 0 Country wide,
Italia
Riding, equestrian tourism,
drift competitions
(jumping, dressage,
complete, endurance) (min
156cm).
Maremmano (http://www.anamcavallomaremmano.com)M - D 1 3
Tuscany
region, Central
Italy
Riding, equestrian tourism,
draught power,
government of livestock
(165/162cm; 500/450kg)
Quarter Horse (http://www.aiqh.it)M - D 1 5
Emilia
Romagna
region, Italy
Riding, equestrian tourism
(160cm; 550/350kg)
Salernitano or Salernitano-Persano
(http://www.agraria.org/equini/salernitano.htm) M-D 4
Campania
region,
Southern Italy
Riding, equestrian tourism
(158/150cm; 500/450kg)
Spanish Purebred or Andalusian (http://www.aipre.com)M - D 1 0
Emilia
Romagna
region, Italy
Sport, hobby (160/155cm;
570kg)
Ventasso (http://www.aia.it/tecnico/equini/a ventass.htm)M - D 8
Emilia-
Romagna
region,
Northern Italy
Equestrian tourism
(164/152cm)
Italian Trotter (http://www.anact.it/)D 6 7 Country wide,
Italy
Selected for competitive
merit as trotter at short and
medium distances
(160–145cm)
Throroughbred (http://www.anacpurosangue.com/)D 1 1 Country wide,
Italy
Racehorses (gallop) and
used for genetic
improvement of Italian
local breeds.
∗BasedoninformationobtainedfromHorseBreedsNationalAssociations,ifavailable.
§Types: B=brachimorphicorheavy,M=mesomorphic,M-D=meso-
dolichomorphic, D= dolichomorphic or light.4 Journal of Biomedicine and Biotechnology
Table 2: Primers, PCR conditions, ampliﬁed regions, and use of the PCR products.
Primer pair F: Forward sequence (5 -3 )
R: Reverse sequence (5 -3 )
Primer annealing
regions
Ampliﬁed region
(bp)∗ PCR conditions
§ Use of the PCR
products
1# 1F: TCAGGGAAACAAGTTTCTCAAAT Promoter 1–484 58/1.5/45/ Sequencing,
1R: TGCTCCACAATGAATCTCG Promoter (484) E PCR-RFLP
2# 2F: TGAATCAGCTCACCCTTGAC Promoter 369–727 62/0.8/45/ Sequencing
2R: CCAGCAACAATCAGCATAAA Exon 1 (360) E
3¶ 3F TGTGCTGATTCTTGCTGGTC Exon 1 710–947 58/1.5/45/ Sequencing
3R: ATCAATCAGTTCCCGGAGTG Exon 1 (238) E
4¶ 4F: GACCCGTCAAGACTCCTACA Exon 2 2982–3226 58/1.0/45/ Sequencing
4F: TGGGAAGGTTACAGCAAGA Exon 2 (245) E
5¶ 5F: AGGCCAATTACTGCTCTGGA Exon 3 5430–5744 58/1.5/45/ Sequencing
5R: ATACTCTAGGCTTATAGCCT 3’ UTR (315) E
6¶ 6F: CACTCCGGGAACTGATTGAT Exon 1 928–3098 58/0.8/130 Sequencing
6R: CGCCTGGGTTCATGTCAAGT Exon 2 (2171) /T
7¶ 7F: AGGCAGGCACATTGCTTAAT Intron 1 1808–2287 58/0.8/45/ Sequencing
7R: GAATGTTATATTCAGGCTATCTCAA Intron 1 (480) E
8¶ 8F: AAATGTGACATAAGCAAATGATTAG Intron 2 5152–5534 62/0.8/45/ Sequencing
8R: AGCAGGGGCCTGCTGAACCTCTGGG Exon 3 (383) E
9¶ 9F: TGCAAAATTGGCTCAAACAG Exon 2 3135–5361 55/0.8/130 Sequencing
9R: CAGCATCGAGATTCTGTGGA Exon 3 (2227) /T
10
¶ 10F: CCCCCAGAAGAGTGTCAAAT Intron 2 3627–4822 60/0.8/130 Sequencing
10R: TCTTTACTTGGGGAAACTTGGA Intron 2 (1196) /T
11 1F: TCAGGGAAACAAGTTTCTCAAAT Promoter 1–204 53/1.2/35/ PCR-RFLP
11R: ACTTCCTCAGAAATTAAGATTTAAT Promoter (204) E
∗Numbering accoding to GenBank accession number GQ183900. §Annealing temperature (◦C), [MgCl2], extension time (s), Taq DNA polymerase (E =
EuroTaq; T = TaKaRa). #Primers pairs 1 and 2 were designed based on conserved sequences of the published cattle, pig, and humans MSTN promoter regions
(GenBank accession numbers AJ310751, AJ133580, and AX058992, respectively).
¶Primer pairs 3–10 were designed based on horse MSTN mRNA sequence
(GenBank accession number AB033541).
polymerase (EuroClone Ltd., Paington, Devon, UK), or 1U
of TaKaRa Ex Taq DNA Polymerase (TaKaRa Bio Inc., Shiga,
Japan)and1×PCRbuﬀerwithMgCl2 concentrationspeciﬁc
for each primer pair (Table 2). PCR conditions were: an
initial step at 95
◦Cf o r5m i n u t e s ,3 5c y c l e so f9 5
◦Cf o r3 0s ,
speciﬁc annealing temperature for each primer pair for 30s,
72
◦C for speciﬁc reaction times for diﬀerent primer pair
(Table 2), and a ﬁnal step at 72
◦C for 9minutes. Genomic
DNA obtained from 12 horses of 10 breeds (1 Bardigiano,
1 Haﬂinger, 1 Italian Saddle, 2 Italian Trotter, 1 Noric, 2
Rapid Heavy Draft, 1 Salernitano, 2 Throroughbred, and 1
Ventasso) constituted the sequencing panel. PCR fragments
obtained from the sequencing panel with primer pairs 1–
10 were puriﬁed using the QIAquick PCR Puriﬁcation Kit
(Qiagen, D¨ usseldorf, Germany) and sequenced on both
strands using the BigDye Cycle Sequencing kit v.3.1 (Applied
Biosystems, Foster City, CA, USA). Sequencing reactions
were electrophoresed in a capillary sequencer (Applied
Biosystems).
2.3. Sequence Analysis, Polymorphism Identiﬁcation, and
Genotyping. Sequences were aligned and processed with
the help of the BioEdit software v.7.0.5.2. Polymor-
phisms were identiﬁed by visual inspection of the electro-
pherograms and sequences were aligned with ClustalW2
program (http://www.ebi.ac.uk/Tools/clustalw2/index.html)
and using BLASTN (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
The horse MSTN promoter sequence was analysed in silico
for the presence of putative transcription factor binding
sites using MatInspector (http://www.genomatix.de/) bioin-
formatics tool. This region of horse MSTN gene was
aligned with that of cattle (AJ310751), goat (AY827576),
human (AX058992), mouse (AY204900), pig (AY8641281),
and sheep (DQ530260) to identify evolutionary conserved
motifs.
PCR-RFLP protocols were designed to genotype two
identiﬁed SNPs (g.26T>C and g.156T>C) in the sam-
pled horses. To genotype the g.26T>C SNP, the ampliﬁed
products of 484bp obtained with primer pair 1 (Table 2)
were digested with RsaI (recognition sequence: GT↓AC).
Brieﬂy, 5–10μL of PCR reaction was restricted with 2.5U
of RsaI (Fermentas, Vilnius, Lithuania) at 37
◦C overnight
and the resulting fragments (g.26T allele=484bp; g.26C
allele=437bp + 47bp) were resolved on 2.0 % agarose gelsJournal of Biomedicine and Biotechnology 5
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Figure 2: Genomic organization of the horse MSTN gene. Exons
are shown as boxes. Solid boxes indicate protein coding regions.
Untranslated regions are shown as striped boxes. Size of the
sequenced regions of the promoter, exons, and introns is reported.
Polymorphisms,indicatedaccordingtoGenBankaccessionnumber
GQ183900, are reported on the genomic organization of the gene.
stained with ethidium bromide. The g.156T>CS N Pw a s
genotyped amplifying a fragment of 204bp with primer
pair 11 (Table 2) that inserted an artiﬁcial restriction site
(with a mismatched reverse primer) for SspI (recognition
sequence: AAT↓ATT) when allele g.156T occurred. The
obtained fragments (g.156T allele=179bp + 25bp; g.156C
allele=204bp) resulting from digestion of 5–10μLo fP C R
reaction with 2.5U of SspI (Fermentas) at 37
◦C overnight
were electrophoresed in 3.5% agarose gels and visualized
with ethidium bromide.
2.4. Statistical Analysis. Allele and genotype frequencies,
observed and expected heterozygosity, and Fst were calcu-
lated using PopGene software v. 1.32 [31]. Fst is a measure
of population diﬀerentiation based on genotypic data. Allele
frequencies among the four groups (B, M, M-D, and
D) were compared using Fisher’s exact test. The haplo-
types of the two promoter SNPs were reconstructed using
PHASE program v. 2.0 [32]. ARLEQUIN software v. 3.1
(http://cmpg.unibe.ch/software/arlequin3) was used for the
analysis of molecular variance (AMOVA) testing the eﬀect
of the morphological types in population diﬀerentiation
with a model including types (four levels: B, M, M-D and
D; and two levels: B + M and M-D + D), types/breeds,
individuals/breeds, and individuals.
3. Results andDiscussion
3.1. Horse MSTN Genomic Structure and Sequence Analysis.
Sequenced fragments of the horse MSTN gene were assem-
bled into one sequence of 5724bp (submitted to GenBank
under accession number GQ183900) that resulted 100%
identical with that that was, in the meantime, annotated in
the EquCab2 horse genome assembly derived from a Thor-
oughbred horse (http://www.ensembl.org/Equus caballus/
Search/, Ensembl release 52-Dec 2009). Our sequence con-
tained 671bp upstream from the ATG start codon, 538bp of
the promoter, and the entire 5 -untranslated region (UTR)
of 133bp, the three exons (except 33bp of exon 1), the two
intervening introns, and 80bp of the 3 -UTR (Figure 2). The
transcription start site of the ﬁrst exon was deduced from
human and bovine MSTN exon 1 sequences [4, 6]. The
coding regions of exons 1, 2, and 3 of the horse MSTN gene
contained 373, 374, and 381bp, respectively. Introns 1 and 2
included 1829bp and 2016bp, respectively, almost the same
length reported in cattle (1840bp and 2033bp, respectively)
and pig (1809bp and 1980bp, respectively) [6, 8]. Intron 1 is
a type 1 intron as it interrupts a codon between the ﬁrst and
second exon whereas intron 2 is a type 0 intron as it divides
the coding sequence between two codons as in other species
[6, 8]. The analysed proximal promoter region and the 5 -
UTR of the horse MSTN exhibited a degree of identity with
thecorrespondingregionsofotherspeciesrangingfrom77%
(mouse) to 90% (pig). Putative consensus DNA sequences
known as transcription factor binding sites, DNA-binding
motifs, or cis-regulatory elements were identiﬁed in the
positive strand of horse promoter (Figure 3). Considering
the general transcription factors, three diﬀerent putative
TATA boxes (TATA-1, TATA-2, and TATA-3) and one CCAAT
box were detected. Among muscle-speciﬁc transcription
factors, four E-boxes (named E1, E2, E3, and E4 boxes,
Figure 3) ,o n ep u t a t i v es i t ef o rm y o c y t es p e c i ﬁ ce n h a n c e r
factor 2 (MEF2 or MEB1) and consensus sequences for
FoxO and SMAD binding sites (CAAAATA and CAGACA,
respectively)familysequenceswereidentiﬁed.Thealignment
ofMSTN promotersequencesacrossdiﬀerentspecies(horse,
cattle, goat, human, mouse, pig, and sheep) revealed that
these DNA-binding motives, particularly close to the TATA-1
surrounding sequence, were highly conserved across species.
In particular, TATA-1 was conserved in all examined species
except mouse, the second TATA sequence (TATA-2) was
conservedacrossallsevenspecies,andTATA-3wasconserved
in all species except pig and mouse. The MEF2 and E-boxes
were conserved in all the considered mammals except in
human and mouse for E-box4. The E-boxes can be activated
by the myogenic regulatory factors (MRFs: MyoD, Myf5,
myogenin, and MRF4). MyoD upregulates MSTN transcrip-
tion [33] and at the same time MSTN inhibits MyoD expres-
sion and activity regulating the diﬀerentiation of myoblasts
into myotubes [34]. MyoD and MRF4 play competitive
roles in myogenesis and might act as molecular switches to
determine myogenic diﬀerentiation and cell proliferation,
respectively [35]. Additional E-boxes were identiﬁed in the
analysed region (such as an E-box located near the TATA-
2 in pig and an additional E-box in all mammalian but
cattle) and in the distal region of the promoter of the other
mammals (not included in Figure 3). In cattle, Spiller et al.
[33] showed the importance of three functional E-boxes (E3,
E4, and E6) of which the E6, occupied by MyoD in vitro and
in vivo, resulted crucial for the MSTN promoter activity. The
close position of functional E-boxes suggests that they might
function as a cluster to better sustain the stability of DNA-
protein. Across the MSTN promoter sequences of all con-
sidered livestock species we identiﬁed the conserved position
of sites matching the consensus for FoxO binding and the
adjacent SMAD box whose presence was not evidenced in
previous works [8, 33, 36]. Recent data demonstrated that
these factors appear to act through independent pathways
but additively to regulate the expression of MSTN and6 Journal of Biomedicine and Biotechnology
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Figure 3: Sequence analysis of the proximal promoter region and 5 -UTR of MSTN gene. Approximately 670bp of the MSTN 5 -ﬂanking
region and 5 -UTR from horse, cattle, goat, human, mouse, pig, and sheep is shown. The consensus for transcription factor binding motives
is shown in bold text and underlined. Numbering of the horse sequence is relative to the ATG start codon. Numbering of E-boxes is relative
to the horse sequence. The two identiﬁed SNPs of horse MSTN gene are indicated with Y (T or C according to the IUPAC nomenclature)
and in red.8 Journal of Biomedicine and Biotechnology
Table 3: Minor allele frequency (MAF) and haplotype (Hap
∗) frequencies of the two promoter SNPs of the MSTN gene in diﬀerent horse
breeds.
Horse breeds Types
§ Number of
horses
MAF
g.26C
MAF
g.156C Hap [T:T] Hap [T:C] Hap [C:T]
Rapid Heavy
Draft B 81 0.12 0.15 0.73 0.15 0.12
Noric B 26 0.06 0.40 0.54 0.40 0.06
Bardigiano M 34 — 0.15 0.85 0.15 —
Haﬂinger M 31 — 0.37 0.63 0.37 —
Lipizzan M 12 0.21 — 0.79 — 0.21
Murgese M 12 — 0.17 0.83 0.17 —
Tolfetano M 7 — 0.29 0.71 0.29 —
Uruguayan
Creole M 35 — 0.24 0.76 0.24 —
Italian Saddle M-D 30 0.05 0.10 0.85 0.10 0.05
Maremmano M-D 13 — 0.12 0.88 0.12 —
Quarter Horse M-D 15 — — 1.00 — —
Salernitano M-D 4 — 0.25 — — —
Spanish
Purebred M-D 10 — — 1.00 — —
Ventasso M-D 8 0.12 — 0.88 — 0.12
Italian Trotter D 67 0.01 — 0.99 — 0.01
Thoroughbred D 11 — 0.05 0.95 0.05 —
∗Haplotypes for the g.26T>C and g.156T>Cp o l y m o r p h i s m s . § Types: B= brachimorphic or heavy, M= mesomorphic, M-D= meso-dolichomorphic, D=
dolichomorphic or light.
contribute to control muscle cell growth and diﬀerentiation
[37, 38]. In addition, FoxO transcription factors plays a
critical role in development ofmuscle atrophyby stimulating
proteolysis and by increasing myostatin expression. Putative
E-boxes were identiﬁed both in intron 1 (six boxes) and in
intron 2 (six boxes) and one putative E-box was located in
the 3 -UTR at seven nucleotides downstream of the TGA
stop codon (data not shown). The presence of E-boxes in
the introns and 3 - U T Ro fe q u i n eMSTN gene has not been
described yet even if their occurrence has been highlighted
recently in introns of porcine MSTN gene [8].
3.2. Identiﬁcation of Polymorphisms in the Horse MSTN Gene.
Sequencing of the panel of horses of diﬀerent morphological
types revealed a total of seven single nucleotide polymor-
phisms (SNPs) (Figure 2). Two transitions were located in
the promoter region at -646 (GQ183900:g.26T>C) and -516
(GQ183900:g.156T>C) bp upstream from the start codon.
The g.26T>C SNP was within a conserved position (except
in mouse) but not within an identiﬁed known functional
motif while the g.156T>C polymorphism was within a TATA
box-like (TATA-3; YATAAA, Figure 3). Sequence alignments
of the MSTN promoter regions of diﬀerent species indicate
that the g.26T and g.156T alleles derive from an ancestral
MSTN sequence as most close species present the indicated
nucleotides (Figure 3 and data not shown). The other ﬁve
SNPs were in intronic regions: four were localized in intron
1 and one in intron 2 (Figure 2). Three of the SNPs of
intron 1 (g.1634T>G, g.2115A>G, and g.2327A>C) were
also recently identiﬁed in Thoroughbred breeds [24]. One
of which (g.2115A>G; indicated by [24] as g.66493737C>T)
has been associated with sprinting ability and racing stamina
in Thoroughbred horses [24]. The remaining SNPs were not
reported by others and represent new polymorphisms of
the horse MSTN gene. None of these intronic SNPs resided
within splice sites or within particularly conserved sequence
elements. No indels and synonymous or nonsynonymous
substitutions were identiﬁed.
3.3. Analysis of Polymorphisms in Breeds with Diﬀerent
Morphological Types and Genetic Diversity Parameters. Allele
frequencies for the two SNPs located in the promoter region
(g.26T>Candg.156T>C)areshowninTable 3.Theg.26T>C
SNP was polymorphic in 6 out of 16 breeds with higher
observed frequency of the g.26C allele in the Lipizzan
breed (0.21). For the g.156T>C polymorphism, the mutant
g.156C allele, which changes the predicted TATA box3-like,
was detected in 11 out 16 breeds and was identiﬁed in
homozygousconditioninafewBardigiano,Haﬂinger,Noric,
Rapid Heavy Draft, and Uruguayan Creole horses.
Haplotypeanalysesofthetwomutationsshowedthepre-
sence of three haplotypes: [g.26T:g.156T], [g.26T:g.156C],Journal of Biomedicine and Biotechnology 9
Table 4: Minor allele frequency (MAF), observed and expected heterozygosity (Het∗), and haplotype (Hap§)f r e q u e n c i e so ft h et w o
promoter SNPs of the MSTN gene in horses with diﬀerent morphological types.
Types
# Number of
horses
MAF
g.26C
MAF
g.156C
Observed Het
(s.d.)
§
Expected Het
(s.d.)
§ Hap [T:T] Hap [T:C] Hap [C:T]
B 107 0.11 0.21 0.24 (0.09) 0.26 (0.10) 0.69 0.22 0.09
M 131 0.02 0.22 0.18 (0.20) 0.19 (0.22) 0.76 0.22 0.02
M-D 80 0.04 0.07 0.11 (0.03) 0.11 (0.03) 0.89 0.08 0.03
D 78 0.01 0.01 0.02 (0.01) 0.02 (0.01) 0.98 0.01 0.01
Total 396 0.05 0.15 0.15 (0.09) 0.17 (0.11) 0.81 0.15 0.04
∗Means for the two loci and standard deviation, in parenthesis. §Haplotypes for the g.26T>C and g.156T>Cp o l y m o r p h i s m s . # Types: B= brachimorphic or
heavy, M= mesomorphic, M-D= meso-dolichomorphic, D= dolichomorphic or light.
and [g.26C:g.156T] (Table 3). The [T:T] haplotype could
be the wild type according to its presence in all breeds and
higher frequency (from 0.54 to 1.00). The [T:C] haplotype
w a so b s e r v e di n1 0b r e e d s( f r e q u e n c yf r o m0 . 0 5t o0 . 4 0 ) ,
whereas the [C:T] haplotype was identiﬁed only in 6 breeds
( f r e q u e n c yf r o m0 . 0 1t o0 . 2 1 )( Table 3).
In order to evaluate if the two SNPs in the promoter
region could account for a quote of variability related to
morphological types, we classiﬁed the analysed horse breeds
in four groups (brachymorphic, B; mesomorphic, M; meso-
dolichomorphic, M-D; and dolichomorphic, D) (see Materi-
als and Methods). Several descriptive statistics summarizing
the genetic diversity of these groups are reported in Table 4.
The B group showed the highest observed and expected
heterozygosity (0.24 ± 0.09 and 0.26 ± 0.10, respectively),
whereas the D group had the lowest values (0.02 ± 0.01 for
both measures). For the g.26T>CS N P ,d i ﬀerences in allele
frequencies were signiﬁcant between B and the other three
groups (P<. 0001 for B versus M and B versus D; P<
.05 for B versus M-D). For the g.156T>Cp o l y m o r p h i s m ,
only the comparison between B and M groups was not
signiﬁcant. In particular, diﬀerences in allele frequencies
were highly signiﬁcant between the B and D groups and
between the M and D groups (P = 3.78E −11 and P =
3.95E − 9, respectively. For the remaining comparisons:
P<. 0001 for B versus M-D and for M versus M-D,
P<. 01 for M-D versus D). The overall Fst value showed
that the genetic diﬀerences among the groups accounted
for 6.1% (3.6% for the g.26T>C SNP and 7.0% for the
g.156T>C SNP) of the genetic variation. The AMOVA
on haplotypes conﬁrmed that a proportion of the total
molecular variance was associated to morphological types of
thehorses.Usingthefourmorphologicaltypesthemolecular
variance explained was 6.40% (P<.05). Grouping these four
types into two groups (B + M and M-D + D) according
to their similarities on morphological types the quote of
explained molecular variance was 10.6% (P<. 01). It
could be possible that diﬀerences of allele and haplotype
frequencies among types are inﬂuenced by phylogenetic
closeness rather than any association with morphological
types. This issue should be further investigated as, to our
knowledge, there are no studies analyzing this question that
include most of the breeds we investigated. However, Di
Stasio et al. [39] analysed genetic relationships among only
three breeds included in our study and evidenced signiﬁcant
genetic diﬀerentiation among Bardigiano, Haﬂinger, and
Maremmano, suggesting that the results we obtained might
notbebiasedbyaputativecommonoriginofthebreeds.The
association of the two promoter SNPs with morphological
types could be due to linkage disequilibrium with alleles
in other chromosome 18 loci that aﬀect the variability
of morphological traits in horses. However, based on our
results it cannot be excluded that MSTN SNPs could
inﬂuence morphological traits, that are indirectly related
to muscle mass. A few SNPs in the promoter region of
the swine MSTN gene were associated with muscularity,
growth, and meat quality traits [8, 20, 21]. One of them,
with high frequency in the muscled Belgian Pietrain breed,
was associated with MSTN expression level, suggesting
that promoter polymorphisms could contribute to muscle
mass in this pig breed [8]. To demonstrate the putative
functionalroleoftheidentiﬁedhorseMSTN promoterSNPs,
expressionstudiesinskeletalmuscleofanimalswithdiﬀerent
genotypes should be performed. However, it is worth to
point out that in vivo RNA expression studies in horses
are very complicated as it is quite diﬃcult to standardize
temporary and permanent environmental factors (i.e. age,
sex, management, feeding, etc.) that are major sources of
variability in such experiments. For these reasons in vitro
assays might be needed to clarify if the identiﬁed SNPs could
alter MSTN gene expression. In addition association analysis
in breeds segregating for the two promoter SNPs and for
which estimated breeding values for several conformational
and performance traits are available could be useful to
further evaluate the association of these polymorphic sites
with phenotypic traits.
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